Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

MNPRMNPR
8 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in MONOPAR THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 112,578 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $10.4M as of 2026-Q2. The position was increased (+12.7% shares). MNPR represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$10.4M

Current Shares

112,578

Total Value Change

+$10.3M

Total Shares Change

+98,512

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
112,578
+12.7%
$10.4M0.0%$92.59
31
2026-Q1
Increased
99,918
+0.9%
$5.5M0.0%$51.88
27
2025-Q4
Increased
99,007
+16.5%
$6.5M0.0%$65.07
32
2025-Q3
Decreased
84,961
-12.3%
$6.9M0.0%$75.90
0
2025-Q2
Increased
96,919
+99.7%
$3.5M0.0%$33.60
43
2025-Q1
Increased
48,540
+25.8%
$1.8M0.0%$40.33
32
2024-Q4
Increased
38,596
+174.4%
$849,1120.0%$23.85
40
2024-Q3
New
14,066
-
$94,8040.0%$6.77
33

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used